Table 1 The clinical data of the patients with PTC
From: LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis
Variable | CALML3-AS1 expression | P value | |
|---|---|---|---|
| Ā | High (nā=ā26) | Low (nā=ā26) | Ā |
Age | |||
ā<ā55 | 15 | 12 | 0.405 |
āā„55 | 11 | 14 | Ā |
Gender | |||
āMale | 13 | 17 | 0.262 |
āFemale | 13 | 9 | Ā |
Extra thyroidal extension | |||
āNegative | 16 | 15 | 0.777 |
āPositive | 10 | 11 | Ā |
Tumor size (cm) | |||
āā¤1 | 17 | 6 | 0.002* |
ā>ā1 | 9 | 20 | Ā |
TNM stage | |||
āI/II | 21 | 19 | 0.510 |
āIII/IV | 5 | 7 | Ā |
Lymph node metastasis | |||
āNegative | 18 | 10 | 0.026* |
āPositive | 8 | 16 | Ā |